A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis
Latest Information Update: 02 Sep 2021
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms CLEAREST
- Sponsors Wyeth Pharmaceuticals
- 26 Jul 2020 Status changed from recruiting to completed.
- 16 Jul 2019 This trial was completed in Ireland, according to European Clinical Trials Database.
- 10 Dec 2012 New trial record